Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy (GlobeNewswire EN) +++ CAPRICOR THERAPEUTICS Aktie -38,34%

BIOAGE LABS Aktie

 >BIOAGE LABS Aktienkurs 
3.97 EUR    (Tradegate)
Ask: 4.04 EUR / 1470 Stück
Bid: 3.9 EUR / 1530 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
BIOAGE LABS Aktie über LYNX handeln
>BIOAGE LABS Performance
1 Woche: +11,1%
1 Monat: +3,6%
3 Monate: +41,8%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>BIOAGE LABS Aktie
Name:  BIOAGE LABS INC. O.N.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US09077V1008 / A40D7P
Symbol/ Ticker:  Y7G (Frankfurt) / BIOA (NASDAQ)
Kürzel:  FRA:Y7G, ETR:Y7G, Y7G:GR, NASDAQ:BIOA
Index:  -
Webseite:  https://bioagelabs.com/
Marktkapitalisierung:  139.87 Mio. EUR
Umsatz:  1.25 Mio. EUR
EBITDA:  -70.63 Mio. EUR
Gewinn je Aktie:  -1.488 EUR
Schulden:  8.92 Mio. EUR
Liquide Mittel:  277.24 Mio. EUR
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  106.91 / 0.5 / -
Gewinnm./ Eigenkapitalr.:  - / -30.2%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  BIOAGE LABS
Letzte Datenerhebung:  11.07.25
>BIOAGE LABS Eigentümer
Aktien: 35.85 Mio. St.
f.h. Aktien: 23.82 Mio. St.
Insider Eigner: 3.63%
Instit. Eigner: 66.65%
>BIOAGE LABS Peer Group

 
22.06.25 - 00:03
 BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions (GlobeNewswire EN)
 
Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy...
17.06.25 - 15:03
 BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank (GlobeNewswire EN)
 
Company to generate and analyze molecular profiles from over 17,000 samples from the HUNT Biobank in Norway to accelerate discovery of drug targets for aging-related diseases...
27.05.25 - 22:33
 BioAge Labs to Present at Upcoming Investor Conferences (GlobeNewswire EN)
 
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:...
06.05.25 - 22:33
 BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire EN)
 
RICHMOND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging, today provided business updates and reported its first quarter 2025 financial results....
20.03.25 - 21:54
 BioAge Labs GAAP EPS of -$6.63 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.03.25 - 21:33
 BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024 (GlobeNewswire EN)
 
Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25...
11.03.25 - 02:33
 Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA (PR Newswire)
 
LOS ANGELES, March 10, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ: BIOA) for violations of the federal securities laws. Shareholders who purchased the Company's securities pursuant and/or......
10.03.25 - 23:36
 BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit (PR Newswire)
 
NEW YORK, March 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to the registration statement for BioAge's initial public offering conducted on September 26, 2024......
10.03.25 - 10:45
 BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA (PR Newswire)
 
NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
10.03.25 - 07:00
 BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, March 10, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ: BIOA) for violations of the federal securities laws. Investors......
06.03.25 - 21:36
 BIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit (PR Newswire)
 
RADNOR, Pa., March 6, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. ("BioAge") (NASDAQ: BIOA) on behalf of those who purchased stock pursuant and/or......
06.03.25 - 18:15
 INVESTOR DEADLINE MONDAY: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIOA (PR Newswire)
 
SAN DIEGO, March 6, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs' registration statement issued in connection with BioAge Labs' initial public......
06.03.25 - 18:01
 BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, March 6, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED......
06.03.25 - 11:45
 The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline (PR Newswire)
 
NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
05.03.25 - 21:48
 BIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit (PR Newswire)
 
NEW YORK, March 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to the registration statement for BioAge's initial public offering conducted on September 26, 2024 (the......
05.03.25 - 16:45
 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BioAge To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BioAge between September 26, 2024 and January 7, 2025 and would like to......
04.03.25 - 18:09
 BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., March 4, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA). IF YOU ARE AN INVESTOR......
04.03.25 - 11:48
 BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline (PR Newswire)
 
NEW YORK, March 4, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely......
03.03.25 - 19:12
 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA (PR Newswire)
 
NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Floh, am Morgen geboren, ist um Mittag eine Großmutter. - Sprichwort Frankreich
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!